Publications by authors named "Gloria Garcia-Villalobos"

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease (NAFLD), is a prevalent hepatic condition linked to metabolic alterations. It gradually causes liver damage and potentially progresses to cirrhosis. Despite its significance, research, especially in the pediatric population, is limited, leading to contradictory findings in diagnosis and treatment.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effects of oral nutritional supplementation (ONS) with and without exercise (EX) on muscle mass and physical function in chronic kidney disease patients over six months.
  • Patients were divided into two groups: one received only ONS while the other received ONS and exercise, with improvements noted in physical functions like gait speed and handgrip strength in both groups.
  • Although both groups showed better physical function, neither group experienced significant improvements in muscle mass quantity or quality, though the ONS + EX group had larger effect sizes in certain physical tests.
View Article and Find Full Text PDF

Objective: Protein energy wasting affects the nutritional status (NS) and physical function (PF) of dialysis patients. Among the different anabolic strategies to improve NS and PF, oral nutritional supplementation (ONS) and resistance exercise (RE) or aerobic exercise (AE) have been shown to be effective. Nevertheless, the combination of both anabolic strategies has not been completely evaluated.

View Article and Find Full Text PDF

Introduction: Despite a systematic increase in the coverage of patients with end-stage renal disease (ESRD) who have received dialytic therapies and transplantation over the past 2 decades, the Mexican health system currently still does not have a program to provide full coverage of ESRD. Our aim was to analyze mortality in patients with ESRD without health insurance.

Methods: This was a prospective cohort study of 850 patients with advanced chronic kidney disease (CKD).

View Article and Find Full Text PDF